United States · 
Who invested in Trigemina?
Trigemina's investors include Aurus.
2010201120122013
$305KVenture$400KVenture$4.5MSeries AUnited States · Series A startup
Who invested in Trigemina
3 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Trigemina and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$5.2Mraised across 3 rounds since 2009, from 3 sources
$305KVenture$400KVenture$4.5MSeries A
- Latest round
- Series A, $4.5MJun 2013
- Step-upi
- 11.3×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $305K Dec 2009
- Biggest round
- $4.5M Series A · Jun 2013
- Usual gap between rounds
- 2.7 years the median of 2
The rounds
- Jun 2013
- Oct 2010Venture$400K
No investor was named in the report.
From a historical funding recordSEC filing: $400K sold, first sale Nov 2010
- Dec 2009Venture$305K
No investor was named in the report.
Reported by deals.venturebeat.comSEC filing: $305K sold, first sale Dec 2009
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Trigemina
How much has Trigemina raised?
Trigemina has raised $5.2M across 3 rounds since 2009.
When did Trigemina last raise?
Trigemina's most recent round was a Series A of $4.5M in Jun 2013.
What was Trigemina's biggest round?
Its most recent round, $4.5M in Jun 2013, is also its largest on record.
Who backed Trigemina first?
Trigemina's first round on record, in Jun 2013, was backed by Aurus.
What stage is Trigemina at?
Trigemina's latest named round is a Series A, in Jun 2013.
Where is Trigemina based?
Trigemina is based in the United States.
Companies like Trigemina
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.